Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rahul Aggarwal

Showing results (141-150 of 223) with videos related to

Pageof 23
Sort By:
European Urology|November 11, 2021
Hyperpolarized 1-[<sup>13</sup>C]-Pyruvate Magnetic Resonance Imaging Detects an Early Metabolic Response to Immune Checkpoint Inhibitor Therapy in Prostate CancerIvan de Kouchkovsky, Hsin-Yu Chen, Michael A Ohliger, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 5, 2025
Imaging Efficacy of [<sup>18</sup>F]CTT1057 PET for the Detection of PSMA-Positive Tumors Using Histopathology as Standard of Truth: Results from the GuideView Phase 2/3 Prospective Multicenter StudyAndrei Iagaru, Jose F Suarez, Spencer Behr, et al.
Journal for Immunotherapy of Cancer|May 11, 2026
Phase 2 study of talabostat, a small molecule inhibitor of dipeptidyl peptidases (DPP), administered in combination with pembrolizumab in patients with small cell neuroendocrine prostate cancerRahul Aggarwal, Jingsong Zhang, Paul Monk, et al.
Prostate Cancer and Prostatic Diseases|November 6, 2019
Hyperpolarized <sup>13</sup>C-pyruvate MRI detects real-time metabolic flux in prostate cancer metastases to bone and liver: a clinical feasibility studyHsin-Yu Chen, Rahul Aggarwal, Robert A Bok, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2024
Framework for the Pathology Workup of Metastatic Castration-Resistant Prostate Cancer BiopsiesMichael C Haffner, Michael J Morris, Chien-Kuang C Ding, et al.
Journal for Immunotherapy of Cancer|May 14, 2021
Pre-existing immune status associated with response to combination of sipuleucel-T and ipilimumab in patients with metastatic castration-resistant prostate cancerMeenal Sinha, Li Zhang, Sumit Subudhi, et al.
Journal of Magnetic Resonance (San Diego, Calif. : 1997)|March 10, 2019
Coil combination methods for multi-channel hyperpolarized <sup>13</sup>C imaging data from human studiesZihan Zhu, Xucheng Zhu, Michael A Ohliger, et al.
Prostate Cancer and Prostatic Diseases|November 21, 2019
Germline polymorphisms associated with impaired survival outcomes and somatic tumor alterations in advanced prostate cancerWilliam S Chen, Eric L Feng, Rahul Aggarwal, et al.
Cancer|June 20, 2020
Tipifarnib in recurrent, metastatic HRAS-mutant salivary gland cancerGlenn J Hanna, Jeffrey P Guenette, Nicole G Chau, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 26, 2025
Early changes of PSMA PET expression after initiation of androgen receptor signaling inhibitors in CRPC: an international multicenter retrospective studyLena M Unterrainer, Andrea Farolfi, Tristan Grogan, et al.
Pageof 23

Showing results (141-150 of 223) with videos related to

Sort By:
Pageof 23
European Urology|November 11, 2021
Hyperpolarized 1-[<sup>13</sup>C]-Pyruvate Magnetic Resonance Imaging Detects an Early Metabolic Response to Immune Checkpoint Inhibitor Therapy in Prostate CancerIvan de Kouchkovsky, Hsin-Yu Chen, Michael A Ohliger, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 5, 2025
Imaging Efficacy of [<sup>18</sup>F]CTT1057 PET for the Detection of PSMA-Positive Tumors Using Histopathology as Standard of Truth: Results from the GuideView Phase 2/3 Prospective Multicenter StudyAndrei Iagaru, Jose F Suarez, Spencer Behr, et al.
Journal for Immunotherapy of Cancer|May 11, 2026
Phase 2 study of talabostat, a small molecule inhibitor of dipeptidyl peptidases (DPP), administered in combination with pembrolizumab in patients with small cell neuroendocrine prostate cancerRahul Aggarwal, Jingsong Zhang, Paul Monk, et al.
Prostate Cancer and Prostatic Diseases|November 6, 2019
Hyperpolarized <sup>13</sup>C-pyruvate MRI detects real-time metabolic flux in prostate cancer metastases to bone and liver: a clinical feasibility studyHsin-Yu Chen, Rahul Aggarwal, Robert A Bok, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2024
Framework for the Pathology Workup of Metastatic Castration-Resistant Prostate Cancer BiopsiesMichael C Haffner, Michael J Morris, Chien-Kuang C Ding, et al.
Journal for Immunotherapy of Cancer|May 14, 2021
Pre-existing immune status associated with response to combination of sipuleucel-T and ipilimumab in patients with metastatic castration-resistant prostate cancerMeenal Sinha, Li Zhang, Sumit Subudhi, et al.
Journal of Magnetic Resonance (San Diego, Calif. : 1997)|March 10, 2019
Coil combination methods for multi-channel hyperpolarized <sup>13</sup>C imaging data from human studiesZihan Zhu, Xucheng Zhu, Michael A Ohliger, et al.
Prostate Cancer and Prostatic Diseases|November 21, 2019
Germline polymorphisms associated with impaired survival outcomes and somatic tumor alterations in advanced prostate cancerWilliam S Chen, Eric L Feng, Rahul Aggarwal, et al.
Cancer|June 20, 2020
Tipifarnib in recurrent, metastatic HRAS-mutant salivary gland cancerGlenn J Hanna, Jeffrey P Guenette, Nicole G Chau, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 26, 2025
Early changes of PSMA PET expression after initiation of androgen receptor signaling inhibitors in CRPC: an international multicenter retrospective studyLena M Unterrainer, Andrea Farolfi, Tristan Grogan, et al.
Pageof 23